Healio1d
FDA approves two new biosimilars of denosumab-dssb
The FDA has approved two new biosimilars of denosumab-dssb to treat osteoporosis, increase bone mass, prevent ...
Managed Healthcare Executive1d
FDA Approves Second Biosimilars for Prolia/Xgeva
Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis ...
Business Wire3d
FDA Approves Samsung Bioepis’ OSPOMYV™, XBRYK™ (denosumab-dssb), a Biosimilar to Prolia and Xgeva
Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...
IEEE5d
OsteoNet—A Framework for Identifying Osteoporosis in Bone Radiograph Images Using Attention-Based VGG Network
Abstract: Diagnosing osteoporosis from X-ray images poses a significant challenge due to the visual similarities between images from healthy subjects and patients. In this paper, we present a novel ...